inhaled glucocorticoid

From Aaushi
Jump to navigation Jump to search
[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]

Indications

Dosage

Pharmacokinetics

Adverse effects

Drug interactions

More general terms

More specific terms

Additional terms

Component of

References

  1. ↑ Journal Watch 20(11):88, 2000 Wong CA et al Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399, 2000 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10791523 Sambrook PN Inhaled corticosteroids, bone density, and risk of fracture. Lancet 355:1385, 2000 PMID: https://www.ncbi.nlm.nih.gov/pubmed/10791519
  2. ↑ 2.0 2.1 Journal Watch 24(4):34, 2004 Suissa S et al Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 169:83, 2004 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14551165
  3. ↑ 3.0 3.1 Prescriber's Letter 8(5):29 2001
  4. ↑ 4.0 4.1 Journal Watch 23(14):114, 2003 Hawkins G et al Stepping down inhaled corticosteroids in asthma: randomised controlled trial. BMJ 326:1115, 2003 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12763981 <Internet> http://bmj.com/cgi/content/full/326/7399/1115
  5. ↑ 5.0 5.1 Prescriber's Letter 11(3):15 2004 Journal Watch 24(5):40, 2004 Harrison TW et al, Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 363:271, 2004 PMID: https://www.ncbi.nlm.nih.gov/pubmed/14751699
  6. ↑ 6.0 6.1 6.2 Journal Watch 24(10):81-82, 2004 Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double- blind, placebo-controlled trial. Mayo Clin Proc. 2004 Apr;79(4):458-66. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15065610
    Lee TA, Weiss KB. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 Apr 1;169(7):855-9. Epub 2004 Jan 07. PMID: https://www.ncbi.nlm.nih.gov/pubmed/14711795
  7. ↑ 7.0 7.1 Prescriber's Letter 12(6): 2005 As-Needed Inhaled Corticosteroids for Mild Persistent Asthma Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210608&pb=PRL (subscription needed) http://www.prescribersletter.com
  8. ↑ Jani M, Ogston S, Mukhopadhyay S. Annual increase in body mass index in children with asthma on higher doses of inhaled steroids. J Pediatr. 2005 Oct;147(4):549-51. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16227047
  9. ↑ 9.0 9.1 9.2 9.3 Hubbard R et al. Use of inhaled corticosteroids and the risk of fracture. Chest 2006 130:1082-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17035441
  10. ↑ 10.0 10.1 Ferguson GT et al. Prevalence and progression of osteoporosis in patients with COPD: Results from the Towards a Revolution in COPD Health Study. Chest 2009 Dec; 136:1456. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19581353
  11. ↑ 11.0 11.1 Suissa S et al. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med 2010 Nov; 123:1001. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20870201
  12. ↑ 12.0 12.1 O'Byrne PM et al. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med 2011 Mar 1; 183:589 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20889908
  13. ↑ 13.0 13.1 Loke YK et al. Risk of fractures with inhaled corticosteroids in COPD: Systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax 2011 Aug; 66:699 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21602540
  14. ↑ Prescriber's Letter 18(10): 2011 Hyperglycemia Associated with Non-oral and Locally Injected Corticosteroids Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=271022&pb=PRL (subscription needed) http://www.prescribersletter.com
  15. ↑ 15.0 15.1 Kelly HW et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012 Sep 3 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22938716 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1203229
  16. ↑ 16.0 16.1 Suissa S et al. Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia. Chest 2015 Nov; 148:1177 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26110239 <Internet> http://journal.publications.chestnet.org/article.aspx?articleid=2363032
  17. ↑ 17.0 17.1 Gray N, Howard A, Zhu J et al Association Between Inhaled Corticosteroid Use and Bone Fracture in Children With Asthma. JAMA Pediatr. Published online November 13, 2017 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29131874 https://jamanetwork.com/journals/jamapediatrics/article-abstract/2661821
  18. ↑ 18.0 18.1 Gonzalez AV, Coulombe J, Ernst P, Suissa S et al. Long-term use of inhaled corticosteroids in COPD and the risk of fracture. Chest 2018 Feb; 153:321. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28716642 <Internet> http://journal.chestnet.org/article/S0012-3692(17)31243-6/fulltext
    Cho YJ, Sin DD. Inhaled corticosteroids and fractures in COPD: Can we finally put this to bed? Chest 2018 Feb; 153:293. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29406210 <Internet> http://journal.chestnet.org/article/S0012-3692(17)31481-2/fulltext
  19. ↑ 19.0 19.1 19.2 Kunoe A, Sevelsted A, Chawes BL et al. Associations between inhaled corticosteroid use in the first 6 years of life and obesity-related traits. Am J Respir Crit Care Med 2021 Sep 15; 204:642. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33975528 https://www.atsjournals.org/doi/10.1164/rccm.202009-3537OC
  20. ↑ 20.0 20.1 NEJM Knowledge+ Complex Medical Care
Retrieved from "https://aaushi.info/w/index.php?title=A5490&oldid=1199779"